Indeed, using a dCas9 fused to the Tet1 demethylase, Liu et al. were able to reverse hypermethylation of the CGG repeat in FXS iPS cells and reactivate FMRP expression (Liu et al., 2018), circumventing the risk associated with genome editing. This evidence concerns the gene FMR1 and fragile X syndrome.